Read the Research

Androgenetic alopecia is the most prevalent form of hair loss in adults. It affects an estimated 50% of men by the age of 50 and a significant proportion of ...

The Wnt/beta-catenin pathway appears repeatedly in any serious reading around hair follicle biology and hair loss. It comes up in discussions of follicle dev...

Hair loss research has long focused on two principal targets: the androgen pathway (addressed by finasteride and dutasteride) and vascular and anagen-prolong...

People using minoxidil as the backbone of a hair loss protocol often want to add further topical actives. 2-Deoxy-D-Ribose is among the more commonly asked-a...

Interest in 2-Deoxy-D-Ribose as a hair serum ingredient is growing, driven by published research linking topical 2dDR to VEGF upregulation and, in a 2024 ani...

The majority of compounds that attract serious attention in topical hair loss research are peptides: GHK-Cu, AHK-Cu, and a growing range of synthetic equival...

If you have spent time reading hair loss product copy, you will have noticed a certain pattern in the language. Products "support the scalp environment," the...

The hair loss product market is large, competitive, and poorly labelled in meaningful parts. A serum can make plausible-sounding claims about copper peptides...

Female pattern hair loss is the most common hair disorder in women, yet it receives substantially less attention in both clinical literature and the hair los...

The two most common causes of hair loss that people investigate online are androgenetic alopecia and telogen effluvium. They are frequently confused, they ca...